Prognosis | Wald | P | Exp(B) | 95% CI for Exp(B) | |
---|---|---|---|---|---|
Lower | Upper | ||||
OS | |||||
Age(year) ≥50 vs.<50 | 1.577 | 0.215 | 1.643 | 0.788 | 3.319 |
Gender Female vs. Male | 3.298 | 0.081 | 2.506 | 0.907 | 6.387 |
Histological type U vs. D | 0.441 | 0.526 | 0.745 | 0.253 | 2.479 |
T classification T2–4 vs. T1 | 9.309 | 0.003a | 3.568 | 1.521 | 6.517 |
N classification N1-3vs. N0 | 12.505 | 0.001a | 2.389 | 1.543 | 4.228 |
Clinical classification II-IVb vs. I | 6.218 | 0.014a | 0.487 | 0.119 | 0.668 |
CXCL5 expression High vs. Low | 4.885 | 0.027 | 1.960 | 1.079 | 3.560 |
CXCR2 expression High vs. Low | 1.295 | 0.255 | 0.691 | 0.365 | 1.307 |
DMFS | |||||
Age(year) ≥50 vs.<50 | 1.267 | 0.234 | 2.137 | 0.802 | 4.304 |
Gender Female vs. Male | 3.137 | 0.091 | 3.267 | 0.798 | 13.223 |
Histological type U vs. D | 0.702 | 0.564 | 0.523 | 0.158 | 2.694 |
T classification T2–4 vs. T1 | 3.236 | 0.079a | 2.413 | 0.903 | 6.446 |
N classification N1-3vs. N0 | 6.533 | 0.004a | 2.578 | 1.131 | 6.327 |
Clinical classification II-IVb vs. I | 2.786 | 0.095a | 0.413 | 0.251 | 1.099 |
CXCL5 expression High vs. Low | 5.169 | 0.023 | 2.740 | 1.149 | 6.532 |
CXCR2 expression High vs. Low | 1.700 | 0.192 | 1.879 | 0.728 | 4.849 |